KRYS KRYSTAL BIOTECH
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 15 analyst firms say about KRYSTAL BIOTECH: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
14 rated views · 15 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8063
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8067
Recent analyst activity · last 90 days
Our tracked history has 12 reports on KRYS from 10 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 3 raised their price target, 1 lowered it and 2 left it unchanged.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Citigroup raised its target from $378.00 (set 5 May 2026) to $412.00 on 3 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Alec Stranahan | Buy | 21 Sep 2026 | 400.00 USD |
| Cantor Fitzgerald | Josh Schimmer | Buy | 9 Jan 2026 | — |
| Chardan Capital Markets | Unnamed analyst | Buy | 3 Aug 2026 | 323.00 USD · 18 Feb 2026 |
| Citigroup | Yigal Nochomovitz | Buy | 3 Nov 2026 | 412.00 USD |
| Evercore ISI | Gavin Clark-Gartner | Buy | 4 Aug 2026 | 380.00 USD |
| Goldman Sachs | Andrea Newkirk | Buy | 24 Sep 2026 | 441.00 USD |
| Guggenheim | Debjit Chattopadhyay | Buy | 18 Sep 2026 | 284.00 USD |
| H.C. Wainwright | Joseph Pantginis | Buy | 2 Nov 2026 | 361.00 USD |
| Jefferies | Roger Song | Buy | 20 Apr 2026 | 474.00 USD |
| RBC Capital Markets | Lisa Walter | Buy | 14 Aug 2026 | Conflicting reports · excluded |
| TD Cowen | Ritu S Baral | Buy | 3 Nov 2026 | 380.00 USD |
| Weiss Ratings | Unnamed analyst | — | 23 Oct 2026 | — |
| William Blair | Lachlan Hanbury-Brown | Buy | 23 Sep 2026 | — |
| Wolfe Research | Kalpit Patel | Hold | 27 Mar 2026 | — |
| Data feed RESEARCH | Research Team | Sell | 23 Oct 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:36 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.